Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 29, 2025, details the results of the Annual Meeting of Stockholders held on that date. The filing covers the election of directors, approval of compensation plans, and ratification of the independent auditor.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Director Elections (Class II): Four directors were elected to serve until the 2028 annual meeting.
- Jason R. Bernhard: 77,464,202 For; 3,295,653 Against.
- William F. Grieco: 71,942,193 For; 8,817,663 Against.
- R. David Kelly: 75,617,133 For; 5,001,549 Against.
- Reeve B. Waud: 63,559,430 For; 17,196,618 Against.
- Incentive Compensation Plan: Stockholders approved an amendment to the Amended and Restated Incentive Compensation Plan (76,887,756 For; 3,934,969 Against).
- Executive Compensation (Say-on-Pay): Stockholders approved, on a non-binding advisory basis, the compensation of Named Executive Officers (74,218,970 For; 6,595,498 Against).
- Frequency of Say-on-Pay Vote: Stockholders selected a one-year frequency for future advisory votes on executive compensation (77,715,693 For 1 Year).
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025 (80,429,896 For; 2,605,815 Against).
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of voting results. The Board has determined to hold annual non-binding advisory votes on executive compensation based on the stockholder selection.
Key Facts for Investor Verification
- Verify the specific terms of the amendment to the Incentive Compensation Plan referenced in Exhibit 10.2.
- Note the significant number of "Against" votes for director Reeve B. Waud (17,196,618) compared to other nominees.
- Confirm the ratification of Ernst & Young LLP for the fiscal year ending December 31, 2025.
- Review the Definitive Proxy Statement filed on April 10, 2025, for detailed background on the proposals and executive compensation specifics.